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Activation of MEK2 is sufficient to induce
skin papilloma formation in transgenic zebrafish
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Chang-Jen Huang3* and Chia-Hsiung Cheng1,2,4*
Abstract
Background: Mutations in mitogen-activated protein kinase (MAPK) kinase 1 (MEK1) that occur during cell proliferation
and tumor formation are well described. Information on the roles of MEK2 in these effects is still limited. We established a
constitutive MEK2 transgenic zebrafish, Tg(krt14:MEK2S219D-GFP), to elucidate the role of MEK2 in skin tumor formation.
Results: We found that both constitutive MEK2 and MEK1 are able to phosphorylate the extracellular signal-regulated
kinase 1 (ERK1) protein. Transient expression of constitutive MEK2 and MEK1 in the zebrafish epidermis induced papillary
formation at 48 h post-fertilization, but no effects were observed due to the expression of MEK1, MEK2, or the dominant
negative form of MEK2. The transgenic zebrafish, Tg(krt14:MEK2S219D-GFP), developed skin papillomas in the epidermis
within 6 days post-fertilization (dpf). The phospho-ERK signal was detected in section of skin papillomas in an
immunohistochemical experiment. Treatment with 50 μM of the MEK inhibitor, U0126, had significantly decreased
the skin papilloma formation in Tg(krt14:MEK2S219D-GFP) zebrafish by 6 dpf. In vitro and in vivo proliferation assay in
COS-1 cells and in Tg(krt14:MEK2S219D-GFP) transgenic fish show significantly increased cell number and Ki-67 signaling.
Conclusion: Our data indicate that MEK2 is sufficient to induce epidermal papilloma formation through MAPK signaling
in zebrafish, and this transgenic model can be used as a new platform for drug screening.
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Background
The Raf/mitogen-activated protein kinase (MAPK) kinase
(MEK)/extracellular signal-regulated kinase (ERK) cascade
is the downstream pathway of Ras which transforms its ef-
fects on its targets [15]. When Ras is activated by a muta-
tion, it was hypothesized that downstream components
will be constitutively activated and corresponding abnor-
mal gene expressions will occur that drive proliferation.
Several model systems of skin tumors in mice have been
established [1–5, 7, 8, 12, 20]. Zebrafish are a very useful
and convenient model organism for studying human
diseases. So far, no squamous skin cell tumor model has
been established in zebrafish [9, 10, 16, 25, 29].
MEK2 was reported to be a factor related to invasion
and metastasis of pancreatic tumors [28]. The expression
of Raf22w, v-Ha-Ras, or v-Src resulted in the constitutive
activation of MEK1 and MEK2 [11]. A mutation of p21ras
in hepatocellular carcinoma (HCC) was associated with
marked changes in expression of the function of MAPK
cascades mainly through MEK1 [19]. MEK1 is important
for skin tumor development, and MEK2 could not com-
pensate for this process with the loss of MEK1 function in
a mouse model [27]. The MEK1 and MEK2 signaling
pathways were not redundant or interchangeable for cell
proliferation in SK-MEL-28 melanoma cells [17].
However, it is unclear if MEK2 constitutively activated
in zebrafish is sufficient to induce epidermal neoplasia.
Herein, we established a stable transgenic zebrafish
model with consistent expression of MEK2S219D under
an epidermal-specific Krt14 promoter using the Tol2-
transposone system to investigate the effects of
MEK2S219D on inducing epidermal neoplasias in vivo.
Further treatment with U0126 in this transgenic zebra-
fish tumor model was used to evaluate the cause of skin
papilloma. We suggest that this model can serve as a
useful platform for cancer drug screening.
* Correspondence: cjibc@gate.sinica.edu.tw; chcheng@tmu.edu.tw
3Institute of Biological Chemistry, Academia Sinica, 128 Academia Rd., Sec 2,
Taipei 115, Taiwan
1Department of Biochemistry and Molecular Cell Biology, School of Medicine,
College of Medicine, Taipei Medical University, Taipei 110, Taiwan
Full list of author information is available at the end of the article
© 2015 Chou et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.




Zebrafish (Danio rerio) were maintained at 28 °C on a 14-
h light/10-h dark cycle. Embryos were incubated at 28 °C,
and different developmental stages were determined ac-
cording to the description in the Zebrafish Book [30].
Total RNA isolation
Total RNA was isolated from fertilized eggs (a pool of
embryos at 12, 24, 36, 48, 72, 96, 120, and 144 h post-
fertilization; hpf ), using the RNAzol reagent (Tel-Test,
Friendswood, TX, USA) according to instructions of the
manufacturer.
Isolation of the full-length mek1, mek2, and erk1 cDNAs of
zebrafish
cDNAs encoding the complete open reading frame
(ORF) of zebrafish mek1/2 and erk1 were obtained by
polymerase chain reaction (PCR) amplification using
gene-specific primers according to the NCBI’s zebrafish
EST database. PCR amplification was performed in a 50-
μl reaction mixture containing 2 μl of first-strand cDNA,
0.5 μg of a forward primer (MEK1-F: 5′-CGG GAT
CCA TGC AGA AAA GGA GGA AG-3′; MEK2-F: 5′-
TAT TGG ATG TCA GTA GAG ACA ACC TGG-3′;
and ERK1-F: 5′-CGG ACA GAA ACG ATG GCG GAA
TCG-3′) and reverse primer (MEK1-R: 5′-GGG AAT
TCC ATT CCC ACA CTG TGA GT-3′; MEK2-R: 5′-
TTC AGC GCT ATG AGT GGG TGT GCT AGG-3′;
and ERK1-R: 5′-CGT GAT GAC TGT CCC TCT CAG
GAG-3′), 1.5 mM MgCl2, 0.2 mM dNTP, and 2.5 units
ExTaq (Takara Shuzo, Shiga, Japan). Samples were incu-
bated in a thermal cycler (SensoQuest, Göttingen,
Germany). PCR amplification was performed; the DNA
fragment of MEK1 and MEK2 was cloned into a pGEM-
T Easy vector (Promega, Madison, WI, USA) as
pGEMT-MEK1 and pGMET-MEK2 plasmids, and the
resultant clones were subjected to a sequencing analysis.
Site-directed mutagenesis of zebrafish MEK1 and MEK2
cDNA
Site-directed mutagenesis was performed to generate
plasmids encoding MEK1/2 mutants (S219D and S223A)
using the pGEMT-MEK1 and pGEMT-MEK2 plasmid as
a template for PCR amplification using specific oligo-
nucleotide primers. The corresponding oligonucleotides
used for PCR reaction were as follows with the altered
bases underlined: MEK1S219D-F: 5′-GGA CAA CTC
ATT GAC GAC ATG GCC-3′, MEK1S219D-R: 5′-GGC
CAT GTC GTC AAT GAG TTG TCC-3′; MEK2S219D-
F: 5′-CAG CTC ATC GAC GAT ATG GCC AAC TCC-
3′, MEK2S219D-R: 5′-GGA GTT GGC CAT ATC GTC
GAT GAG CTG-3′; and MEK2S223A-F: 5′-ATG GCC
AAC GCC TTC GTT GGA ACA CGG-3′, MEK2S223A-
R: 5′-CCG TGT TCC AAC GAA GGC GTT GGC CAT-
3′. Sequences of the resultant plasmids were verified using
DNA sequencing.
Construction of the expression plasmids
The 4-kb upstream region of the zebrafish krt14 gene
(krt14 promoter) was amplified from a BAC clone,
DKEYP-113D7 (Source Biosicence, Nottingham, UK),
and inserted into the pGEM-T Easy cloning vector (Pro-
mega, Madison, WI, USA) as pGMET-krt14-pro plas-
mid. The krt14 promoter was then inserted into the
pTol2-GFP vector [14] at appropriate sites to generate
the pTol2-krt14-GFP plasmid. MEK1, MEK1S219D,
MEK2, MEK2S219D, MEK2S223A, and ERK1 were
inserted into pcDNA3-mCherry, pcDNA3-GFP, and
pcDNA3-HA from PCR products as pcDNA3-MEK1-
mCherry, pcDNA3-MEK1S219D-GFP, pcDNA3-MEK2-
GFP, pcDNA3-MEK2S219D-GFP, pcDNA3-MEK2S223A-
GFP, pcDNA3-ERK1-HA and then inserted into the pTol2-
krt14-GFP vector to generate pTol2-krt14-MEK1-mCherry,
pTol2-krt14-MEK1S219D-GFP, pTol2-krt14-MEK2-GFP,
pTol2-MEK2S223A-GFP, and pTol2-krt14-MEK2S219D-
GFP plasmids. The pcDNA3-GFP and pcDNA3-mCherry
plasmids were constructed by inserting cDNA corre-
sponding to the green fluorescence protein (GFP) and
mCherry coding-region into pCMV-HA-YUN, which was
a gift from Dr. H.J. Kung (Davis Cancer Center, University
of California, Sacramento, CA, USA).
Microinjection of expression plasmid into zebrafish embryo
The expression plasmid was adjusted to a final concen-
tration of 100 μg/ml in 1× Danieau solution (5 mM
HEPES at pH 7.6, 58 mM NaCl, 0.7 mM KCl, 0.4 mM
MgSO4, and 0.6 mM Ca(NO3)2) containing 0.5 % phenol
red and injected into a zebrafish embryo in the one-cell
stage using the Narishige IM 300 microinjector system
(Narishigi Scientific Instrument, Tokyo, Japan).
Cell culture and plasmid transfection
Monkey kidney fibroblast COS-1 cells (ATCC CRL-1650;
VA, USA) were cultured in high-glucose Dulbecco’s modi-
fied Eagle’s medium (DMEM; Hyclone, UT, USA), supple-
mented with 10 % fetal bovine serum (FBS; Hyclone, UT,
USA) in a humidified atmosphere of 5 % CO2 at 37 °C.
COS-1 cells were transfected with pcDNA3, pcDNA3-
MEK1-mCherry, pcDNA3-MEK1S219D-GFP, pcDNA3-
MEK2-GFP, pcDNA3-MEK2S219D-GFP, pcDNA3-ERK1-
HA plasmids, using Lipofectamine Plus reagent (Life
technologies, Grand Island, NY, USA) according to
manufacturer’s manner. Culture cells were harvested
at 48 h post-transfection and lysed with lysis buffer.
The protein level was analyzed by western blotting.
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Immunoblot analysis
Total cell lysates from transfected cells were harvested and
separated on 10 % sodium dodecylsulfate (SDS)-polyacryl-
amide gels and transferred to polyvinylidene difluoride
(PVDF) membranes. Membranes were blocked with 5 %
skim milk in phosphate-buffered saline (PBS) for 1 h at
room temperature and then incubated at 4 °C with an anti-
HA monoclonal antibody, anti-Actin polyclonal antibody
(Santa Cruz, Dallas, TX, USA), and anti-mCherry poly-
clonal antibody (GeneTex, Hsinchu, Taiwan). Signals were
detected using Immobilon Western Chemiluminescent
HRP Substrate (Millipore, Billerica, MA, USA).
Subcellular localization and image analysis
COS-1 cells transfected with pcDNA3-ERK1-HA alone or
with pcDNA3-MEK1-mCherry, pcDNA3-MEK1S219D-
GFP, pcDNA3-MEK2-GFP, pcDNA3-MEK2S219D-GFP,
and pcDNA3-MEK2S223A-GFP for 48 h were fixed with 4
% paraformaldehyde and permeabilized in PBS with 0.1 %
Triton X-100. Immunostaining was performed using an
anti-HA antibody at 4 °C overnight, followed by incubation
with a Cy2-conjugated goat anti-mouse antibody or Cy3-
conjugated goat anti-mouse antibody for 30 min and DAPI
(1 μg/ml) for 5 min at room temperature. Photoimages
were prepared using an Olympus IX70-FLA inverted fluor-
escence microscope (Olympus, Tokyo, Japan) equipped
with the SPOT system (Diagnostic Instruments, Sterling
Heights, MI, USA).
Histology and Immunohistochemistry
Larvae in which a skin papilloma had formed from
Tg(krt14-MEK2S219D-GFP) at 6 days post-fertilization
(dpf) were fixed with 4 % paraformaldehyde for 1 day and
dehydrated with 100 % methanol. Specimens were embed-
ded in paraffin, sliced and stained with hematoxylin and
eosin (H&E) or incubated with 3 % serum at room
temperature for 1 h before incubation with an anti-pERK
polyclonal antibody (Santa Cruz, Dallas, TX, USA) or
anti-Ki-67 polyclonal antibody (GeneTex, Hsinchu,
Taiwan) containing 5 % serum and 2 mg/ml bovine serum
albumin (BSA) at 4 °C overnight. After washing with
PBST, embryos were incubated with a horseradish perox-
idase (HRP)-conjugated goat anti-rabbit secondary anti-
body at room temperature for 3 h. HRP labeling was
visualized using DAB (Merck, Darmstadt, Germany) as a
substrate. Nuclei were counterstained with hematoxylin
(Merck, Darmstadt, Germany).
Chemical treatment and statistical analysis
Tg(krt14-GFP) and Tg(krt14-MEK2S219D-GFP) embryos
were dechorionated at 1 dpf. Ten embryos with high GFP
fluorescent signaling were transferred to each well in 1 ml
water containing 50 μM U0126 (Sigma, MO, USA) or
0.01 % DMSO (Sigma, MO, USA) and incubated from 1
to 6 days at 28 °C incubator. The number of zebrafish
forms any papilloma was assessed at 6 dpf under an
Olympus IX70-FLA inverted fluorescence microscope.
Results from three independent experiments are
expressed as the mean ± standard deviation (SD). Statis-
tical significance between groups was determined by an
unpaired Student’s t-test. A probability of p < 0.001 was
indicated as ***.
Cell proliferation assay
Cell proliferation was performed by trypan blue assay.
Briefly, 3x104 COS-1 cells were seeded in 24-well plate
overnight. COS-1 cells were transfected with 1 μg
pcDNA3-GPF or pcDNA3-MEK2S219D-GFP plasmids
using Lipofectamine Plus reagent (Life technologies, Grand
Island, NY, USA) according to manufacturer’s manner.
Culture cells were trypsinized and the number of viable
cells was virtually counted with a hemocytometer at day 1,
2, 3 and 4 post-transfection. Three counts per well were
performed on three different experiments. Statistical signifi-
cance between groups was determined by an unpaired
Student’s t-test. A probability of p < 0.05 was indicated as *.
Results
Cloning and characterization of the zebrafish mek1 and
mek2 (mek2a) cDNAs
The MEK family has 7 members, MEK1 ~MEK7, in
mammals. According to genomic predictions from NCBI
zebrafish EST/cDNA, we identified 7 mek genes (mek1,
mek2, mek3, mek4a, mek4b, mek5, and mek7) in zebra-
fish. Phylogenetic analysis of these 7 MEK proteins with
mammalian counterparts indicated that only MEK3 but
not MEK6 was found in zebrafish; instead, there is a du-
plication of MEK4 to form MEK4A and MEK4B. Each
member of the MEK family was separated into individ-
ual monophyletic groups (Fig. 1a).
The mek1 and mek2 cDNAs were isolated from mixed
cDNA pools prepared from different developmental
stages of zebrafish embryos by PCR amplification. Full-
length cDNA of zebrafish mek1 and mek2 were 1191
and 1194 base-pair long, encoding two proteins of 396
and 397 amino acid residues, respectively. The overall
amino acid sequence of zebrafish MEK1 showed 76 %
identity and 85 % similarity to that of MEK2. The zebra-
fish MEK1 respectively showed 88 and 87 % identities to
human and mouse MEK1 and shown 78 % identities to
human and mouse MEK2 at the level of amino acid se-
quences (Fig. 1b). The encoded amino acid sequence of
zebrafish MEK1 and MEK2 was highly homologous to
human and mouse proteins. The phosphorylated site of
MEK1 was also conserved (Fig. 1b, arrow). These data
suggest that zebrafish MEK1 and MEK2 are highly con-
served with mammalian MEK1 and MEK2.
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Both MEK1 and MEK2 phosphorylated the ERK1 protein
In the MAPK signaling pathway, ERK proteins are phos-
phorylated by activated MEK1 and MEK2 to induce
downstream gene transcription. Phosphorylation at serine
218 and 222 at human MEK1 by the Raf protein activated
ERK1/2 phosphorylation. To elucidate the phosphoryl-
ation activity of zebrafish MEK1 and MEK2, we identified
and cloned the mek1, mek2, and erk1 cDNAs from zebra-
fish embryonic cDNA. The human MEK1 phosphoryl-
ation sites of serine 218 and 222 were identified as serine
219 and 223 of zebrafish MEK1 and MEK2 (Fig. 1b). Site-
directed mutations of S219D and S223A were performed
at zebrafish MEK1 and MEK2 as MEK1S219D, MEK2S219D,
and MEK2S223A. Expression plasmid constructs of zebra-
fish MEK1, MEK1S219D, MEK2, MEK2S219D, MEK2S223A,
and ERK1 were constructed into the pcDNA3-mCherry,
pcDNA3-GFP, and pcDNA3-HA plasmids to produce
pcDNA3-MEK1-mCherry, pcDNA3-MEK1S219D-GFP,
pcDNA3-MEK2-GFP, pcDNA3-MEK2S219D-GFP, pcDNA3-
MEK2 S223A, and pcDNA3-ERK1-HA, respectively.
Transfection of the pcDNA3-ERK1-HA plasmid
individually or with the pcDNA3-MEK1-mCherry,
pcDNA3-MEK1S219D-GFP, pcDNA3-MEK2-GFP, or
pcDNA3-MEK2S219D-GFP plasmid into COS-1 cells
was used to detect phosphorylation of ERK1. A Western
blot analysis showed that MEK1 and MEK2 were unable
to phosphorylate ERK1. In contrast, constitutively acti-
vated MEK1S219D and MEK2S219D could phosphorylate
ERK1 (Fig. 2a). These data suggest that zebrafish MEK1
and MEK2 both exhibit ability to phosphorylate ERK1.
It has been shown recently that overexpression of the
ERK protein without active signaling caused its accumu-
lation in the nuclei and the cytoplasm. In the presence
of the active MEK protein, the ERK protein was
Fig. 1 a. Phylogenetic analysis of the MEK gene family in the human,
mouse, and zebrafish. Each member of the MEK family was separated
into individual monophyletic groups. Amino acid sequences were
aligned with ClustalW. Accession numbers for these sequences are as
follows: zMEK1 (NP_998584), hMEK1 (NP_002746), mMEK1 (NP_032953),
zMEK2 (zMEK2a, NP_001032468), zMEK2b (NP_001121753), hMEK2
(NP_109587), mMEK2 (NP_075627), hMEK3 (NP_659731), mMEK3
(NP_032954), zMEK4A (NP_991299), zMEK4B (NP_001082890),
hMEK4 (AAH60764), mMEK4 (NP_033183), zMEK5 (NP_001107789),
hMEK5 (AAA96146), mMEK5 (BAA82040), zMEK6 (NP_571799), hMEK6
(AAB05035), mMEK6 (AAH75652), zMEK7 (XP_689405), hMEK7 (O14733),
mMEK7 (Q8CE90). b. Protein sequence alignment of zebrafish MEK1
and MEK2 with those of the human and mouse. The predicted protein
kinase domain is indicated. The amino acid sequence of zebrafish MEK1
showed high conservation with human (88 % identity and 94 %
similarity) and mouse MEK1. Zebrafish MEK1 shared 76 % identity
and 85 % similarity in the protein sequence with MEK2. Mutation
sites of the constitutively activated (S219D) and dominant negative
(S223A) forms of zebrafish MEK1 and MEK2 are indicated. Accession
numbers for these sequences are as follows: zMEK1 (NP_998584), hMEK1
(NP_002746), mMEK1 (NP_032953), zMEK2 (zMEK2a, NP_001032468),
zMEK2b (NP_001121753), hMEK2 (NP_109587), mMEK2 (NP_075627)
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Fig. 2 (See legend on next page.)
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translocate from nuclei into the cytoplasm [18]. To
further characterize the functions of MEK1 and
MEK2, we examined the cellular localization of ERK1.
In GFP, MEK1 or MEK2 expressed COS-1 cells, the
ERK1 protein was accumulated in the nuclei and
cytoplasm (Fig. 2b. A1-A4, B1-B4, D1-D4; arrow). In
the presence of active MEK1S219D-GFP and
MEK2S219D-GFP, the ERK1 protein was located in the
cytoplasm (Fig. 2b, C1-C4, E1-E4). These results indi-
cate that active zebrafish MEK1 and MEK2 both are
able to induce ERK1 protein translocate from nuclei
to the cytoplasm.
Transient expression of MEK1S219D and MEK2S219D induced
papillary formation in the zebrafish epidermis
It was reported that constitutive activation of MEK1
could transform normal intestinal epithelial cells into
tumors [7]. MEK1 and MEK2 were reported to be
functionally redundant in epidermal development in
mouse models [26]. MEK1 is important in skin tumor
development, and MEK2 cannot compensate for loss
of MEK1 function [27]. Another report indicated that
MEK2 is sufficient for melanoma cell proliferation,
but MEK1 is not [17]. To study the role of zebrafish
MEK2 in the formation of skin tumors and compari-
son of expression with MEK1, pTol2-krt14-MEK2-
GFP, pTol2-MEK2S219D-GFP, pTol2-MEK2S223A-
GFP, pTol2-MEK1-mCherry and pTol2-MEK1S219D-
GFP were microinjected into one-cell stage of zebra-
fish embryos and revealed the expression at 3 dpf.
The zebrafish embryos injected with pTol2-krt14-
MEK2-GFP (Fig. 3b), pTol2-Krt14-MEK2S223A-GFP
(Fig. 3c), and pTol2-krt14-MEK1-mCherry (Fig. 3e)
displayed specific GFP or mCherry expression in the
skin cells (Fig. 3a). The pTol2-krt14-MEK2S219D-
GFP-injected embryos also displayed specific expres-
sion in the skin cells. Furthermore, several skin cells
in the upper epidermis were shown to have papillae
and to have budded (Fig. 3d, arrows). The pTol2-
krt14-MEK1S219D-GFP transgenic embryos also dis-
played papillae and budded skin cell formation in the
epidermis (Fig. 3f ). These results suggest that active
zebrafish MEK2 and MEK1could promote the prolif-
eration of skin cells to form papillae.
MEK2 is sufficient to induce skin papilloma formation in
transgenic zebrafish
To further elucidate the tumorigenesis of MEK2 in
zebrafish, we established a transgenic zebrafish known as
Tg(krt14:MEK2S219D-GFP) in which expression of the
MEK2S219D-GFP fusion protein was driven by the
krt14 promoter to establish a skin tumor animal model.
The skin papilloma formation of Tg(krt14:MEK2S219D-
GFP) was presented approximately 34 % in homozygous
and 5 % in heterozygous. Tg(krt14:MEK2S219D-GFP)
zebrafish expressed the GFP signal from embryos to
adult. Tg(krt14:MEK2S219D-GFP) zebrafish exhibited
skin papilla from 3 dpf (Fig. 4b-B’) and then developed
to a skin tumor at 6 dpf (Fig. 4c-C’, d-D’, e-E’; white-dots
area). In addition, we established a transgenic line
known as Tg(krt14:GFP), in which GFP expression was
driven by the krt14 promoter to reveal the expression
pattern of skin cells. Homozygous Tg(krt14:GFP) trans-
genic zebrafish exhibited the GFP signal in the entire
skin cells, which was a normal phenomenon from em-
bryos to adult (Fig. 4a-A’). These results indicated that
constitutive MEK2 was sufficient to induce skin papil-
loma formation.
To further examine whether skin papilloma formation
induced by MEK2 is through downstream signaling acti-
vation, we tested ERK phosphorylation of skin papilloma
by an IHC experiment. Phosphorylated ERK is well
known as a proliferation marker during tumor forma-
tion. Phosphorylation of ERK in skin papilloma of
Homozygous Tg(krt14:MEK2S219D-GFP) larvae was de-
tected by IHC experiment (Fig. 4f-F’). These results sug-
gested that zebrafish constitutive activated MEK2S219D
induced skin papilloma formation through phosphoryl-
ation of downstream ERK signaling.
U0126 inhibits skin papilloma formation induced by
MEK2S219D
We further examined whether skin papilloma formation
in Tg(krt14:MEK2S219D-GFP) zebrafish was induced by
MEK2 activation by specific MEK1/2 inhibitor, U0126.
Tg(krt14:MEK2S219D-GFP) transgenic zebrafish were
incubated in 50 μM U0126 or 0.01 % DMSO (Control)
from 1 to 6 dpf. No significantly abnormal phenotype of
Tg(Krt14:GFP) zebrafish larvae was observed by treated
with U0126 at 2 and 6 dpf (Fig. 5a, b). No skin papilloma
(See figure on previous page.)
Fig. 2 Constitutively activated MEK1 (MEK1S219D) and MEK2 (MEK2S219D) both phosphorylated ERK1. a. COS-1 cells were transiently transfected with
pcDNA3-HA, pcDNA3-ERK1-HA, pcDNA3-MEK1-mCherry, pcDNA3-MEK1S219D-GFP, pcDNA3-MEK2-GFP, or pcDNA3-MEK2S219D-GFP. Total lysates were
analyzed by Western blotting using anti-HA, anti-GFP, anti-pERK monoclonal antibodies; anti-mCherry and anti-Actin polyclonal antibodies. b. Intracellular
localization of ERK1, MEK1, and MEK2 in COS-1 cells by fluorescent microscopy. The pcDNA3-ERK1-HA was co-transfected with pcDNA3-GFP (A1-A4),
pcDNA3-MEK1-mCherry (B1-B4), pcDNA3-MEK1S219D-GFP (C1-C4), pcDNA3-MEK2-GFP (D1-D4), or pcDNA3-MEK2S219D-GFP (E1-E4). Cy2 or Cy3 dye
used an anti-HA monoclonal antibody to detect localization of ERK1 as visualized. DAPI was used to stain nuclear DNA. White arrows indicate the ERK1
protein localized in nuclei and the cytoplasm. IB, immunoblot
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was observed at 2 dpf in Tg(krt14:MEK2S219D-GFP) zeb-
rafish larvae (Fig. 5c). Incubated Tg(krt14:MEK2S219D-
GFP) zebrafish larvae with 50 μM at 2 dpf or 0.01 %
DMSO as control, no skin papilloma was observed in
U0126 treatment at 6 dpf (Fig. 5d) but several skin papil-
loma was observed in DMSO treatment at 6 dpf (Fig. 5e).
The skin papilloma formation in transgenic zebrafish
larvae was presented 90 % in DMSO treatment and 10 %
Fig. 3 Transient expressions of MEK1 and MEK2 driven by the krt14 promoter induced papillae formation in skin cells. Lateral view of pTol2-krt14-GFP
(a), pTol2-krt14-MEK2-GFP (b), pTol2-MEK2S223A-GFP (c), pTol2-krt14-MEK2S219D-GFP (d), pTol2-krt14-MEK1-mCherry (e), and pTol2-krt14-MEK1S219D-GFP
(f) plasmids, which were microinjected into 1-cell stage of zebrafish embryos and visualized at 3 days post-fertilization (dpf). The arrow indicates skin cell
papillae and budding in the upper epidermis. The upper panel is a fluorescent image. The middle panel is merged fluorescent and bright-field images.
The lower panel is an enlargement of the white box in the middle panel
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Fig. 4 (See legend on next page.)
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in U0126 treatment at 6 dpf (Fig. 5f). These results sug-
gest that the skin papilloma formation in Tg(krt14:
MEK2S219D-GFP) zebrafish larvae can be inhibited by
the specific MEK inhibitor, U0126. The MEK2S219D is
sufficient to induce skin papilloma formation through ac-
tivation of MAPK pathway.
In vitro and in vivo cell proliferation assay in COS-1 cells
and Tg(krt14:MEK2S219D-GFP) transgenic zebrafish
To further assess the effect of proliferation induced by
MEK2S219D, we performed the in vitro cell proliferation
and in vivo proliferation assay in Tg(krt14:MEK2S219D-
GFP) transgenic zebrafish. COS-1 cells was seeded to
(See figure on previous page.)
Fig. 4 Skin tumor formation in Tg(krt14: MEK2S219D-GFP) zebrafish. Skin cells proliferated and formed papilla from 3dfp (b, B’, white arrow) on
the yolk skin in Tg(krt14: MEK2S219D-GFP) embryos to form a skin tumor at 6 dpf (c, and C’; lateral view, d and D’, white-dots area; ventral view,
e and E’, white-dots area). Tg(krt14:GFP) embryos had developed normal skin cells at 6 dpf (a, A’). An immunohistochemical experiment was used
to detect ERK phosphorylation in skin tumors. p-ERK was detected by a p-ERK monoclonal antibody and visualized by DAB (brown). Nuclei were
counterstained with hematoxylin (blue) (f, F’)
Fig. 5 The MEK inhibitor, U0126, inhibited skin tumor formation in Tg(krt14: MEK2S219D-GFP) embryos. Tg(Ka14:GFP) embryos were observed by
treated with 50 μM U0126 at 2 dpf (a) and 6 dpf (b). Tg(krt14: MEK2S219D-GFP) embryos were observed by treated with 50 μM U0126 at 2 dpf
(c) and 6 dpf (d) or treated with DMSO at 6 dpf (e). The white arrow indicated skin papilloma. f The frequency of tumor formation in Tg(krt14:
MEK2S219D-GFP) embryos incubated with DMSO (Control) or U0126
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24-well for 24 h and then transfected with pcDNA3-
GFP or pcDNA3-MEK2S219D-GFP plasmid. The cell
number of transfected COS-1 cells was counted using
trypan blue assay at day 1 to day 4. The cell number
of transfected with pcDNA3-MEK2S219D-GFP was
found significantly higher than transfected with
pcDNA3-GFP (Control) at 3 and 4 day post-
transfection (Fig. 6a). The in vivo proliferation assay
was performed using H&E and IHC staining in
Tg(krt14:MEK2S219D-GFP) transgenic zbrafish. The
proliferation cells were detected in papilloma (black-
dots area) by H&E staining (Fig. 6b). Significantly, the
much higher proportion of Ki-67 staining was de-
tected in the epithelium of the yolk (Fig. 6c). Taking
together, these data further support the contention
that the constitutive activated MEK2 could induce
proliferation in vitro and induce papilloma formation
in transgenic zebrafish.
Discussion
In this study, we established a transgenic zebrafish
model to explore the role of MEK2 in skin tumor forma-
tion. Constitutive MEK1 and MEK2 phosphorylated
ERK1 and induced downstream MAPK signaling activa-
tion. Transient expression of constitutive MEK2 and
MEK1 in the epidermis had induced skin papillary for-
mation at 3 dpf. Sporadic skin papilloma formation was
revealed in the epidermis of Tg(krt14-MEK2S219D-GFP)
transgenic zebrafish and had developed into skin tumors
at 6 dpf. Treatment with U0126 could reduce skin tumor
formation in Tg(krt14-MEK2S219D-GFP) transgenic
zebrafish.
The functions of MEK1 and MEK2 in the Ras/Raf/
Mek/Erk signaling pathway were well documented. Dur-
ing epidermal neoplasia formation, MEK2 and MEK1
showed mostly similar functions, but each had several
differences. In zebrafish, the functions of MEK1 and
Fig. 6 Effect of MEK2S219D on cell proliferation was analyzed in COS-1 cells and in transgenic zebrafish. a The pcDNA3-MEK2S219D-GFP and
pcDNA3-GFP (control) plasmids was transfected to COS-1 cells and evaluated the cell numbers by trypan blue assay from 1 to 4 days post-transfection.
Results represent the mean of three independent determinations. * p< 0.05. b H&E-stained section in papilloma (black-dots area) of transgenic zebrafish.
c Ki-67 IHC staining in papilloma (black-dots area) of transgenic zebrafish
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MEK2 have not yet been characterized. From a phylo-
genic analysis, we identified and isolated zebrafish mek1
and mek2 cDNAs. We also isolated the downstream erk1
cDNA to characterize the function of these two MEK
proteins. An in vitro experiment showed that both
MEK1 and MEK2 were able to phosphorylate down-
stream ERK1 by causing it to mutate to the constitutive
active form. The ERK1 protein is then translocate from
nuclei to the cytoplasm. We conclude that zebrafish
MEK1 and MEK2 could activate downstream gene ex-
pression through Erk1 phosphorylation.
The role of MEK2 in skin tumor development is still
being debated. MEK2 functions in mouse melanoma
formation but does not contribute to skin tumor forma-
tion [17, 26, 27]. Those transgenic mice that contained
chemically induced carcinomas or knockout mice were
used to characterize the functions of MEK1 and MEK2.
The krt14-MEK1 transgenic mice exhibited moderate
hyperplasia with spontaneous skin tumor formation at
5 weeks. Downstream signaling is activated by ornithine
decarboxylase (ODC) expression [7]. Surprisingly, skin
tumors was sporadically formed just within 6 days in
our Tg(krt14-MEK2S219D-GFP) transgenic zebrafish.
The zebrafish MEK2 was sufficient to induce skin
tumor formation through ERK1 activation.
In previous reports, the function of MEK1 was import-
ant in skin tumor formation. In our results, transient ex-
pression of activated MEK1 was produced papillary
formation in the epidermis. The skin papilloma was also
revealed in activated MEK2 expression. Although we did
not establish transgenic zebrafish by expression of acti-
vated MEK1, we suggest that MEK1 also potentially to
induce skin papilloma formation. Moreover, transient
expression of constitutive MEK2 in the epidermis in-
duced papillary formation. These papillae were then ex-
cised from the epidermis and placed in the medium.
Collection of this skin cells and cultured in L15 medium
could be continuously maintained for more than 1 week.
Analysis of these skin cells showed intact nuclei, tubulin
structure, and cell shape (data not shown). We suggest
that these skin cells were experiencing hyper-proliferation
due to MEK2 activation. This observation may be relevant
to psoriasis but needs further investigation.
Ras proto-oncogenes are central regulators activating
intracellular Ras-Raf-MEK-ERK signaling pathway in
tumorigenesis. The zebrafish is increasingly used as a ver-
tebrate model for studying tumorigenesis and drug
screening. A transgenic approach is generally used for es-
tablishing a transgenic zebrafish. The Tg(fabp10:EGFP-
krasv12) trangenic zebrafish specifically overexpressed high
level of krasv12 in liver and progressed to hyperplasia and
malignant tumor [22, 23]. Furthermore, the transgenic
zebrafish overexpressed the BRAFV600E-mutated gene ac-
tivated under microphthalmia-associated transcription
factor (mitf ) promoter induced melanocyte prolifera-
tion [25]. The transgenic zebrafish also overexpressed
krasG12V gene by using a pancreas specific transcrip-
tion factor 1a promoter expressed in the pancreases,
which caused pancreatic neoplasia [6]. The overex-
pression of the krasG12V gene driven by cytokeratin 5
(krt5) or glial fibrillary acidic protein promoter in-
duced brain tumor [13]. Mutagenesis induced by a
random insertion into the genome through a Tol2
transposon-mediated transgenic approach was used as
new method for studying gene function during develop-
ment [14, 21, 24]. A Tol2 transposon-mediated enhancer
trap contains GFP without a promoter was used for estab-
lishing transgenic lines, but no phenotype was observed in
37 transgenic lines [14]. The aforementioned method
driven by the mini keratin8 promoter in the Tol2
transposon-mediated approach increased the transgenic
efficiency to 16 %, but only 3.57 % of genes were inserted
into the coding region [24]. The Tol2 transposon-
mediated enhancer-trap using an hsp70 promoter-driven
GFP was used to screen gene mutagenesis. The transgenic
efficiency was increased to 70 % but only 2.73 % recessive
mutations were identified [21]. To date, no gene mutation
induced by Tol2 transposon-mediated enhancer trap has
induced tumorigenesis. In our study, we established a
Tol2 transposon-mediated Tg(Ka14:MEK2S219D-GFP)
transgenic zebrafish by using a Ka14 promoter to consti-
tutively activate MEK2S219D-GFP expression. Skip papil-
loma was observed at 3–6 dpf, and no other tumor type
was observed in this transgenic line. We also established a
Tg(Tol2:GFP) transgenic line by using Tol2 transposon-
mediated approach, which did not display skin papilloma.
Although we could not complicatedly exclude the possi-
bility of a random insertion to the oncogene upstream of
MEK and induction of the skin papilloma formation, we
suggested that the frequency was extremely rare.
In summary, we showed that MEK2 is sufficient to in-
duce skin papilloma formation. In vitro and in vivo ex-
periments showed that activated MEK2 in MAPK
pathway promoted downstream signaling through ERK1
phosphorylation. This activation could be inhibited by
U0126 and reduced skin papilloma formation in trans-
genic zebrafish. This Tg(krt14-MEK2S219D-GFP) is the
first established skin tumor model in zebrafish and could
provide for anticancer drug screening to target the
MAPK cascade.
Conclusions
Most cancer was associated with constitutive activa-
tion of ERK signaling, which was activated ERK1/2 by
MEK1 and MEK2 upon activation of receptor tyrosine
kinase. Our data supported that the constitutive acti-
vation of MEK2 was sufficiently induced tumor
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formation in Tg(krt14:MEK2S219D-GFP) transgenic
zebrafish. This transgenic zebrafish might be provided
for anticancer drug screening.
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